Suhrud Rajguru, Ph.D.
Dr. Rajguru is the Director of the South Florida Regional I-Corps@NCATS Program at the University of Miami. He is also an Associate Professor in Biomedical Engineering and Otolaryngology, Co-Director of the Institute for Neural Engineering and Assistant Director of the Team Science program at the Miami Clinical and Translational Science Institute (CTSI). Dr. Rajguru is the co-founder and Chief Scientific Officer of Restor-Ear Devices, LLC. His research foci are on the investigations of pathophysiology, the diagnosis and treatment of various hearing and balance disorders. He has authored numerous peer-reviewed publications and is a named inventor on several issued and pending patent applications. His research is supported by the National Institutes of Health and industry partners and he is actively involved in the education and mentoring of undergraduate and graduate students. Dr. Rajguru led the University of Miami CTSI’s pilot program for the I-Corps@NCATS in 2016. Today, it is one of 22 I-Corps@NCATS programs at Clinical and Translational Science Award (CTSA) hubs across the country.
Mr. Storey is a National Instructor for both the National Science Foundation’s I-Corps™ and for the National Institute of Health’s I-Corps @ NIH™ program. In addition to his role at the US national level, he has been the principal instructor for international cohorts in the I-Corps & Lean Start-up arena in South America and Asia/Pacific, as well as lead instructor for the US State Department’s Global Initiative for Innovation in Technology programs in Southern and Western Africa.
Hassan Al-Ali, Ph.D., M.S.M.
Dr. Al-Ali is an Assistant Professor of Neurosurgery and Medicine at the University of Miami, Miller School of Medicine. He is a biochemist by training with specialty in early-stage drug discovery for neurological, nephrological, and oncological disorders. Hassan received his MSc in Biochemistry from the American University of Beirut, and PhD in Molecular Biology and Biophysics from the University of Miami. He also has a Masters in Business Management from the University of Miami School of Business. At the Miami Project to Cure Paralysis, he led the development of a novel drug target identification strategy (idTRAX) that combines cell-based screening, biochemical target-based profiling, and machine learning. To commercialize idTRAX, Dr. Al-Ali co-founded Truvitech where he serves as the Chief Scientific and Chief Operating Officer. He is a previous graduate of the ICORPS@NCATS course, and has received STTR funding for his startup.
William Silverman, Ph.D., MBA
Dr. William Silverman is an ion channels biophysicist by training, with over a decade of experience supporting startup companies. After earning his MBA from UM’s Herbert Business School, he began a second career supporting entrepreneurs and advising startup companies at the University’s Launch Pad. While there, he advised on the launch of nearly 300 companies, and trained staff at 17 universities across the United States to open their own entrepreneurship centers. In 2018, Dr. Silverman joined U Innovation at the UM Miller School of Medicine as the Executive Director of the Coulter Program and New Ventures, where he works with promising biomedical technologies and medical innovators and advising medical school faculty on translational research projects. He is the co-founder of Accredify, Inc., an angel capital-supported fintech company serving online capital markets.